483 Strides Pharma Science May 2019

483 Strides Pharma Science May 2019

Rumany Penn FDA$119.00 - Available Now

FDA investigators audited the Strides Pharma Science - Bangalore, India facility and issued inspectional observations (via FDA 483) on 24 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2019
  • Location: Bangalore, India
  • FEI: 3004554612
Add To Cart